187 related articles for article (PubMed ID: 24740810)
1. TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.
Reglińska-Matveyev N; Andersson HM; Rezende SM; Dahlbäck B; Crawley JT; Lane DA; Ahnström J
Blood; 2014 Jun; 123(25):3979-87. PubMed ID: 24740810
[TBL] [Abstract][Full Text] [Related]
2. Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.
Somajo S; Ahnström J; Fernandez-Recio J; Gierula M; Villoutreix BO; Dahlbäck B
Thromb Haemost; 2015 May; 113(5):976-87. PubMed ID: 25716664
[TBL] [Abstract][Full Text] [Related]
3. Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S.
Ahnström J; Andersson HM; Hockey V; Meng Y; McKinnon TA; Hamuro T; Crawley JT; Lane DA
Blood; 2012 Dec; 120(25):5059-62. PubMed ID: 23074276
[TBL] [Abstract][Full Text] [Related]
4. Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.
Santamaria S; Reglińska-Matveyev N; Gierula M; Camire RM; Crawley JTB; Lane DA; Ahnström J
J Biol Chem; 2017 Jun; 292(22):9335-9344. PubMed ID: 28420729
[TBL] [Abstract][Full Text] [Related]
5. Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP.
Teraz-Orosz A; Gierula M; Petri A; Jones D; Keniyopoullos R; Folgado PB; Santamaria S; Crawley JTB; Lane DA; Ahnström J
Blood Adv; 2022 Jan; 6(2):704-715. PubMed ID: 34731882
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
[TBL] [Abstract][Full Text] [Related]
7. The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition.
Ndonwi M; Tuley EA; Broze GJ
Blood; 2010 Aug; 116(8):1344-51. PubMed ID: 20479289
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.
Thomassen MC; Heinzmann AC; Herfs L; Hartmann R; Dockal M; Scheiflinger F; Hackeng TM; Rosing J
J Thromb Haemost; 2015 Jan; 13(1):92-100. PubMed ID: 25348176
[TBL] [Abstract][Full Text] [Related]
9. Protein S is a cofactor for tissue factor pathway inhibitor.
Rosing J; Maurissen LF; Tchaikovski SN; Tans G; Hackeng TM
Thromb Res; 2008; 122 Suppl 1():S60-3. PubMed ID: 18691502
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tissue factor-factor VIIa-catalyzed factor X activation by factor Xa-tissue factor pathway inhibitor. A rotating disc study on the effect of phospholipid membrane composition.
Salemink I; Franssen J; Willems GM; Hemker HC; Lindhout T
J Biol Chem; 1999 Oct; 274(40):28225-32. PubMed ID: 10497177
[TBL] [Abstract][Full Text] [Related]
11. Functional properties of the sex-hormone-binding globulin (SHBG)-like domain of the anticoagulant protein S.
Saposnik B; Borgel D; Aiach M; Gandrille S
Eur J Biochem; 2003 Feb; 270(3):545-55. PubMed ID: 12542704
[TBL] [Abstract][Full Text] [Related]
12. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.
Wood JP; Ellery PE; Maroney SA; Mast AE
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):169-76. PubMed ID: 24233490
[TBL] [Abstract][Full Text] [Related]
13. Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.
Augustsson C; Svensson A; Kjaer B; Chao TY; Wenjuan X; Krogh BO; Breinholt J; Clausen JT; Hilden I; Petersen HH; Petersen LC
J Thromb Haemost; 2018 May; 16(5):893-904. PubMed ID: 29532595
[TBL] [Abstract][Full Text] [Related]
14. TFPI-dependent activities of protein S.
Peraramelli S; Rosing J; Hackeng TM
Thromb Res; 2012 May; 129 Suppl 2():S23-6. PubMed ID: 22425215
[TBL] [Abstract][Full Text] [Related]
15. New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma.
Alshaikh NA; Rosing J; Thomassen MCLGD; Castoldi E; Simioni P; Hackeng TM
J Thromb Haemost; 2017 May; 15(5):950-960. PubMed ID: 28211163
[TBL] [Abstract][Full Text] [Related]
16. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.
Hackeng TM; Seré KM; Tans G; Rosing J
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3106-11. PubMed ID: 16488980
[TBL] [Abstract][Full Text] [Related]
17. Activated protein C up-regulates procoagulant tissue factor activity on endothelial cells by shedding the TFPI Kunitz 1 domain.
Schuepbach RA; Velez K; Riewald M
Blood; 2011 Jun; 117(23):6338-46. PubMed ID: 21474669
[TBL] [Abstract][Full Text] [Related]
18. Human tissue factor pathway inhibitor fused to CD4 binds both FXa and TF/FVIIa at the cell surface.
Riesbeck K; Dorling A; Kemball-Cook G; McVey JH; Jones M; Tuddenham EG; Lechler RI
Thromb Haemost; 1997 Dec; 78(6):1488-94. PubMed ID: 9423800
[TBL] [Abstract][Full Text] [Related]
19. Role of exosite binding modulators in the inhibition of Fxa by TFPI.
Peraramelli S; Thomassen S; Heinzmann A; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M; Rosing J
Thromb Haemost; 2016 Mar; 115(3):580-90. PubMed ID: 26607136
[TBL] [Abstract][Full Text] [Related]
20. The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.
Gierula M; Salles-Crawley II; Santamaria S; Teraz-Orosz A; Crawley JTB; Lane DA; Ahnström J
J Thromb Haemost; 2019 Dec; 17(12):2056-2068. PubMed ID: 31364267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
